Dihydroalprenolol

Dihydroalprenolol.svg

Dihydroalprenolol is a beta-adrenergic receptor antagonist, commonly known as a beta blocker. It is a derivative of alprenolol, which is used in the treatment of hypertension and angina pectoris. Dihydroalprenolol is primarily used in research settings to study beta-adrenergic receptors due to its high affinity for these receptors.

Chemical Structure and Properties

Dihydroalprenolol is a synthetic compound with the chemical formula C15H25NO2. It is a racemic mixture of two enantiomers. The compound is characterized by its ability to bind to beta-adrenergic receptors, inhibiting the action of endogenous catecholamines like epinephrine and norepinephrine.

Mechanism of Action

As a beta blocker, dihydroalprenolol works by blocking the beta-adrenergic receptors in the heart and vascular system. This action leads to a decrease in heart rate, myocardial contractility, and blood pressure. By inhibiting these receptors, dihydroalprenolol reduces the effects of sympathetic nervous system stimulation.

Uses in Research

Dihydroalprenolol is not typically used in clinical practice but is valuable in pharmacological research. It is often used in radioligand binding assays to study the density and affinity of beta-adrenergic receptors in various tissues. This research helps in understanding the role of these receptors in different physiological and pathological conditions.

Pharmacokinetics

The pharmacokinetics of dihydroalprenolol involve its absorption, distribution, metabolism, and excretion. It is well-absorbed after oral administration and undergoes extensive first-pass metabolism in the liver. The metabolites are primarily excreted via the kidneys.

Side Effects and Precautions

As a research compound, dihydroalprenolol is not typically associated with clinical side effects. However, beta blockers in general can cause bradycardia, hypotension, fatigue, and dizziness. Caution is advised when interpreting research data, as these effects can influence experimental outcomes.

Related Compounds

Dihydroalprenolol is related to other beta blockers such as propranolol, metoprolol, and atenolol. These compounds share similar mechanisms of action but differ in their pharmacokinetic profiles and clinical uses.

See Also

• Beta blocker
• Beta-adrenergic receptor
• Hypertension
• Angina pectoris
• Radioligand binding assay

External Links

-

‎